Teladoc Health Inc (TDOC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
Teladoc Health Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period
Return on Investment, Quarterly Results, Trends, Rankings, Statistics
What is Teladoc Health Inc's ROI in the second quarter of 2026?
Teladoc Health Inc recorded a cumulative net loss of $-177 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -8.15%.
Within the Healthcare sector 246 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2907 to 2980.
Teladoc Health, Inc. (NYSE: TDOC), the pioneering global leader in whole-person virtual care, has recently reported the issuance of inducement awards to two new employees. This development comes at a crucial time for the company, as it grapples with a decline in its stock performance and the recording of a significant net loss. Teladoc Health Inc s stock has experienced a negative trend, declining by -15.27% over the past 30 days. This decrease may have raised concerns among investors who are closely monitoring the company s performance and growth potential. Furthermore, Teladoc Health Inc recorded a cumulative net loss of $-233 million during the 12 months ending in the first quarter of 2024. As a result, it experienced a negative return on investment (ROI) of -6.07%.
In a significant development, Teladoc Health, Inc. (NYSE: TDOC), the pioneering global leader in whole-person virtual care, disclosed today that Jason Gorevic, its previous Chief Executive Officer, will be leaving the company with immediate effect. As a result, the Board of Directors has nominated Mala Murthy, a seasoned industry veteran and the current Chief Financial Officer of the company, to take on the role of acting CEO while actively searching for a permanent successor to fill Mr. Gorevic s shoes. With an illustrious career in the healthcare industry, Mala Murthy has been instrumental in spearheading the company s financial strategies and has served as the Companys Chief Financial Officer since 2019. Despite temporarily assuming the CEO responsibilities, Ms. Murthy will continue to fulfill her role as CFO during this transition period, ensuring stability and continuity within the organization. Teladoc Health has always been at the forefront of transforming healthcare delivery, leveraging innovative telemedicine technologies to provide comprehensive and accessible virtual care for individuals. The company s departure from the current leadership is expected to have a considerable impact on its share price, which experienced a decline of -3.5% during the second quarter of 2024.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
